Article Information
History
- September 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Hye Kyung Lee1,*,
- Manuela A. Hoechstetter2,*,
- Maike Buchner3,4,*,
- Trang Thu Pham2,
- Jin Won Huh5,
- Katharina Müller6,7,
- Sabine Zange6,7,
- Heiner von Buttlar6,7,
- Philipp Girl6,7,
- Roman Wölfel6,7,
- Lisa Brandmeier3,
- Lisa Pfeuffer3,
- Priscilla A. Furth8,
- Clemens-Martin Wendtner2,#,† and
- Lothar Hennighausen1,#,†
- 1National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
- 2Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University (LMU), Munich, Germany
- 3Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany
- 4TranslaTUM - Central Institute for Translational Cancer Research, Technische Universität München, 81675 Munich, Germany
- 5Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 6Bundeswehr Institute of Microbiology, Munich, Germany
- 7German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany
- 8Departments of Oncology & Medicine, Georgetown University, Washington, DC, USA
- ↵†Correspondence: LH (lotharh{at}nih.gov) and CMW (clemens.wendtner{at}muenchen-klinik.de)
Posted September 21, 2022.
Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccination
